A revolutionary technology developed within the
Trabolsi Research Group at NYU Abu Dhabi (NYUAD) could dramatically
improve the wellbeing of diabetic patients: an insulin oral
delivery system that could replace traditional subcutaneous
injections without the side effects caused by frequent
injections.